Subscribe to this collection to receive daily e-mail notification of new additions

	Title	Author(s)	Issue Date	Views
	Host and viral predictive factors of spontaneous hepatitis B surface antigen seroclearance in chronic hepatitis B patients	Kan, Karin簡嘉穎 Advisor(s):Mak, LYYuen, RMFSeto, WKW	2022	1
	Adipokines, inflammation & adverse clinical outcomes in type 2 diabetes	Lee, Chi Ho李智豪	2022	3
	The role of AIM2 inflammasome in systemic lupus erythematosus	Chow, Jia Xin曹嘉欣 Advisor(s):Chan, VSFLau, WCS	2022	4
	Development of therapeutic approach to Wilson's disease using liposome-encapsulated curcumin	Ho, Wai In何慧賢 Advisor(s):Tse, HF	2021	1
	Metagenomic sequencing of gut microbiome and antibiotic resistance genes after antibiotics therapy for Helicobacter pylori	Wang, Lingling王玲玲 Advisor(s):Leung, WKHung, FNI	2021	1
	Role of hepatic protein arginine methyltransferase 1 in obesity-induced metabolic disorders	Xu, Lu徐璐 Advisor(s):Xu, AWang, YWong, CM	2020	21
	Using self-blood pressure monitoring to improve hypertension control in patients with lower health literacy	Fu, Sau Nga傅秀雅	2021	29
	The circulating enzyme peptidase M20 domain containing 1 (PM20D1) as a metabolic sensor : molecular basis and clinical implications	Yang, Ranyao楊然耀	2021	27
	Hepatocyte clonal expansion and hepatitis B virus DNA integration in patients with long-term nucleos(t)ide analogue therapy	Chow, Ning鄒寧	2021	33
	Modeling Bietti's crystalline dystrophy by employing patients' induced pluripotent stem cells and CRISPR/Cas9 technique	Zhang, Zhao張昭	2018	14
	Novel therapeutics for the treatment of obesity and its related metabolic complications	Chan, Tsz Fung陳梓烽	2021	12
	Non-invasive assessment of liver outcomes in chronic hepatitis B infection	Mak, Loey Lung Yi麥龍兒	2021	35
	Islet macrophage inflammation and pathogenesis of type 2 diabetes	Zhang, Di張締	2021	15
	G protein-coupled receptors (GPCRs) in the regulation of obesity and metabolic complications	Li, Sin Ki李倩祈	2021	17
	ADAM17 as a therapeutic target in obesity and type 2 diabetes	Sun, Wenzhao孙文昭	2021	11
	Role of glucose transporter 1 in metabolic health and disease	Shao, Baoyi	2021	11
	Immunoprofiling as biomarkers for responses to immunotherapy in advanced hepatocellular carcinoma	Ting, Chi Pung Vox丁志芃 Advisor(s):Yau, TCCKwong, YLCheung, TTWong, CCL	2021	25
	Immunomodulatory effects of hiPSC-MSCs on the therapeutic efficacy of cell-based therapy for cardiovascular diseases	Sun, Sijia孫思佳 Advisor(s):Tse, HFHai, SHJJ	2021	17
	Time trend, risk and prevention of gastrointestinal bleeding in Hong Kong : a population-based study	Guo, Chuanguo郭傳国 Advisor(s):Leung, WKYuen, RMF	2021	35
	The development of drug delivery systems for treating metabolic diseases	Ho, Jacqueline Wai Ying何慧英	2021	31